295 related articles for article (PubMed ID: 38424408)
1. The Multiple Functions of HB-EGF in Female Reproduction and Related Cancer: Molecular Mechanisms and Targeting Strategies.
Zhang Y; Tang L; Liu H; Cheng Y
Reprod Sci; 2024 Feb; ():. PubMed ID: 38424408
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
3. Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer.
Tang XH; Deng S; Li M; Lu MS
Tumour Biol; 2016 Apr; 37(4):5521-8. PubMed ID: 26572150
[TBL] [Abstract][Full Text] [Related]
4. Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy.
Tsujioka H; Yotsumoto F; Hikita S; Ueda T; Kuroki M; Miyamoto S
Curr Opin Obstet Gynecol; 2011 Feb; 23(1):24-30. PubMed ID: 20966750
[TBL] [Abstract][Full Text] [Related]
5. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation.
Leach RE; Khalifa R; Ramirez ND; Das SK; Wang J; Dey SK; Romero R; Armant DR
J Clin Endocrinol Metab; 1999 Sep; 84(9):3355-63. PubMed ID: 10487711
[TBL] [Abstract][Full Text] [Related]
6. The anti-tumor effect of cross-reacting material 197, an inhibitor of heparin-binding EGF-like growth factor, in human resistant ovarian cancer.
Tang XH; Deng S; Li M; Lu MS
Biochem Biophys Res Commun; 2012 Jun; 422(4):676-80. PubMed ID: 22609777
[TBL] [Abstract][Full Text] [Related]
7. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation.
Yoo HJ; Barlow DH; Mardon HJ
Dev Genet; 1997; 21(1):102-8. PubMed ID: 9291586
[TBL] [Abstract][Full Text] [Related]
8. [Role and mechanism of the regulation of nuclear factor-κB by heparin binding-epidermal growth factor-like growth factor in the induction of paclitaxel resistance of ovarian cancer].
Tang XH; Lu MS; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2019 Apr; 54(4):255-261. PubMed ID: 31006192
[No Abstract] [Full Text] [Related]
9. Heparin-Binding Epidermal Growth Factor-Like Growth Factor Enhances Aquaporin 3 Expression and Function During Mouse Embryo Implantation.
Fang CX; Nong YQ; Liu FH; Fan L; Chen Y
Reprod Sci; 2017 Mar; 24(3):463-470. PubMed ID: 27436370
[TBL] [Abstract][Full Text] [Related]
10. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation.
Lessey BA; Gui Y; Apparao KB; Young SL; Mulholland J
Mol Reprod Dev; 2002 Aug; 62(4):446-55. PubMed ID: 12112577
[TBL] [Abstract][Full Text] [Related]
11. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.
Yagi H; Yotsumoto F; Miyamoto S
Mol Cancer Ther; 2008 Oct; 7(10):3441-51. PubMed ID: 18852147
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression.
Wang Y; Li J; Ying Wang C; Yan Kwok AH; Leung FC
Endocrinology; 2007 Jul; 148(7):3426-40. PubMed ID: 17395697
[TBL] [Abstract][Full Text] [Related]
13. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy.
Miyamoto S; Hirata M; Yamazaki A; Kageyama T; Hasuwa H; Mizushima H; Tanaka Y; Yagi H; Sonoda K; Kai M; Kanoh H; Nakano H; Mekada E
Cancer Res; 2004 Aug; 64(16):5720-7. PubMed ID: 15313912
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer.
Yagi H; Yotsumoto F; Sonoda K; Kuroki M; Mekada E; Miyamoto S
Int J Cancer; 2009 Mar; 124(6):1429-39. PubMed ID: 19048624
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin stimulation may not affect the expression of heparin-binding epidermal growth factor-like growth factor in the murine endometrium.
Ku SY; Jee BC; Suh CS; Kim SH; Choi YM; Kim JG; Moon SY
Gynecol Obstet Invest; 2005; 59(4):179-83. PubMed ID: 15703469
[TBL] [Abstract][Full Text] [Related]
16. Dual source and target of heparin-binding EGF-like growth factor during the onset of implantation in the hamster.
Wang X; Wang H; Matsumoto H; Roy SK; Das SK; Paria BC
Development; 2002 Sep; 129(17):4125-34. PubMed ID: 12163414
[TBL] [Abstract][Full Text] [Related]
17. Co-existence of heparin-binding epidermal growth factor-like growth factor and pinopodes in human endometrium at the time of implantation.
Stavreus-Evers A; Aghajanova L; Brismar H; Eriksson H; Landgren BM; Hovatta O
Mol Hum Reprod; 2002 Aug; 8(8):765-9. PubMed ID: 12149409
[TBL] [Abstract][Full Text] [Related]
18. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium.
Birdsall MA; Hopkisson JF; Grant KE; Barlow DH; Mardon HJ
Mol Hum Reprod; 1996 Jan; 2(1):31-4. PubMed ID: 9238654
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the expression of heparanase and heparin-binding EGF-like growth factor in the implantation window of nonconceptual cycle endometrium.
Wirstlein PK; Mikołajczyk M; Skrzypczak J
Folia Histochem Cytobiol; 2013; 51(2):127-34. PubMed ID: 23907942
[TBL] [Abstract][Full Text] [Related]
20. Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Potent Target for Breast Cancer Therapy.
Lian C; Ruan L; Shang D; Wu Y; Lu Y; Lü P; Yang Y; Wei Y; Dong X; Ren D; Chen K; Liu H; Tu Z
Cancer Biother Radiopharm; 2016 Apr; 31(3):85-90. PubMed ID: 27093342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
